First Commercial Zika Test Approved by FDA

Share this content:
First Commercial Zika Test Approved by FDA
First Commercial Zika Test Approved by FDA

FRIDAY, April 29, 2016 (HealthDay News) -- The first commercial test to diagnose Zika virus was approved Thursday by the U.S. Food and Drug Administration.

The test, from Quest Diagnostics, uses the same method that government labs use to check for Zika virus in a person's blood, NBC News reported.

Currently, it can be difficult for people who think they are infected with Zika to get tested. Their doctors have to send samples to local or state health departments. With the FDA approval, doctors will be able to order the $500 test through Quest. The company said results can be available three to five days after a sample arrives, NBC News reported.

The company will charge $120 for patients who don't have health insurance and whose health providers verify they are eligible for the lower price.

More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

Global Prevalence of Insufficient Activity 27.5 Percent

Global Prevalence of Insufficient Activity 27.5 Percent

Levels of insufficient physical activity stable between 2001, 2016; increase seen in high-income countries

HTN Tx Intensification Common Upon Discharge in U.S. Vets

HTN Tx Intensification Common Upon Discharge in U.S. ...

Fourteen percent of older adults admitted to hospital for non-cardiac conditions had intensification of tx

Quarterly Canakinumab Reduces Risk for Gout Attacks

Quarterly Canakinumab Reduces Risk for Gout Attacks

Doesn't affect serum uric acid levels over time, but targets interleukin-1β

is free, fast, and customized just for you!




Already a member?

Sign In Now »